Skip to search.
 TSX Up 0.09% TSX Ventures Down 0.06%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
3.59 0.00(0.00%) 11:24AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:3.59
Open:3.60
Bid:3.58 x 2700
Ask:3.59 x 1400
1y Target Est:6.50
Beta:2.29
Earnings Date:Aug 10 - Aug 14 (Est.)
Day's Range:3.51 - 3.70
52wk Range:1.94 - 5.48
Volume:522,239
Avg Vol (3m):1,754,480
Market Cap:423.17M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
IDRA 0.00%423.17M
DVAXDown 3.08%926.14M
PFEUp 1.62%214.87B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,068.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.46
Quarterly EPS Est (Jun-15) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback